HNF1β confers resistance to oxidative stress of ovarian clear cell carcinoma

被引：1
|
作者：
Amano, Yasuaki [1 ]
Yamaguchi, Ken [1 ]
Mandai, Masaki [2 ]
Matsumura, Noriomi [1 ]
Hamanishi, Junzo [1 ]
Baba, Tsukasa [1 ]
Yamanoi, Koji [1 ]
Murphy, Susan K. [3 ]
Konishi, Ikuo [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Kyoto, Japan
[2] Kinki Univ, Sch Med, Sayama, Osaka 589, Japan
[3] Duke Univ, Div Gynecol Oncol, Durham, NC USA
来源：
CLINICAL CANCER RESEARCH | 2013年 / 19卷
关键词：
D O I：
10.1158/1078-0432.OVCA13-PR08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR08
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Cystic kidney disease, chromophobe renal cell carcinoma and TCF2 (HNF1β) mutations
    Lebrun, G
    Vasiliu, V
    Bellanné-Chantelot, C
    Bensman, A
    Ulinski, T
    Chrétien, Y
    Grünfeld, JP
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2005, 1 (02): : 115 - 119
  • [32] Expression of HNF-1β in Ovarian Carcinomas with Clear Cells
    Kao, Y. C.
    Lin, M. C.
    Mao, T. L.
    LABORATORY INVESTIGATION, 2009, 89 : 220A - 220A
  • [33] Diagnostic accuracy of HNF1?, Napsin A and P504S/Alpha-Methylacyl-CoA Racemase (AMACR) as markers of endometrial clear cell carcinoma
    Travaglino, Antonio
    Raffone, Antonio
    Arciuolo, Damiano
    Santoro, Angela
    Inzani, Frediano
    Di Maio, Anna
    Visiello, Umberto
    Fulgione, Caterina
    Guida, Maurizio
    Mollo, Antonio
    Insabato, Luigi
    Zannoni, Gian Franco
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [34] Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma
    Li, Qing
    Zeng, Xin
    Cheng, Xue
    Zhang, Jingmin
    Ji, Jie
    Wang, Jinsong
    Xiong, Kemei
    Qi, Qiong
    Huang, Wenbin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (07): : 8305 - 8310
  • [35] The proteome of clear cell ovarian carcinoma
    Ji, Jennifer X.
    Cochrane, Dawn R.
    Negri, Gian Luca
    Colborne, Shane
    Miko, Sandra E. Spencer
    Hoang, Lynn N.
    Farnell, David
    Tessier-Cloutier, Basile
    Huvila, Jutta
    Thompson, Emily
    Leung, Samuel
    Chiu, Derek
    Chow, Christine
    Ta, Monica
    Kobel, Martin
    Feil, Lucas
    Anglesio, Michael
    Goode, Ellen L.
    Bolton, Kelly
    Morin, Gregg B.
    Huntsman, David G.
    JOURNAL OF PATHOLOGY, 2022, 258 (04): : 325 - 338
  • [36] The HNF-1 beta-USP28-Claspin pathway upregulates Chkl phosphorylation in ovarian clear cell carcinoma.
    Yamada, Yuki
    Yoshimoto, Chiharu
    Kawaguchi, Ryuji
    Kobayashi, Hiroshi
    CANCER SCIENCE, 2018, 109 : 233 - 233
  • [37] HNF1α maintains pancreatic α and β cell functions in primary human islets
    Qian, Mollie F.
    Bevacqua, Romina J.
    Coykendall, Vy M. N.
    Liu, Xiong
    Zhao, Weichen
    Chang, Charles A.
    Gu, Xueying
    Dai, Xiao-Qing
    MacDonald, Patrick E.
    Kim, Seung K.
    JCI INSIGHT, 2023, 8 (24)
  • [38] Phenotypic effects of the forced expression of HNF4 and HNF1α are conditioned by properties of the recipient cell
    Bailly, A
    Späth, G
    Bender, V
    Weiss, MC
    JOURNAL OF CELL SCIENCE, 1998, 111 : 2411 - 2421
  • [39] CpG Island Methylation within the TCF2 Promoter May Enable Epigenetic Modulation of HNF1-beta and Clear Cell Phenotype in Ovarian Clear Cell Carcinoma
    Cuff, J.
    Huang, S.
    Higgins, J. P.
    Longacre, T. A.
    Pollack, J. R.
    LABORATORY INVESTIGATION, 2009, 89 : 210A - 210A
  • [40] CpG Island Methylation within the TCF2 Promoter May Enable Epigenetic Modulation of HNF1-beta and Clear Cell Phenotype in Ovarian Clear Cell Carcinoma
    Cuff, J.
    Huang, S.
    Higgins, J. P.
    Longacre, T. A.
    Pollack, J. R.
    MODERN PATHOLOGY, 2009, 22 : 210A - 210A
12345